跳至主要内容
临床试验/ACTRN12620001149954
ACTRN12620001149954尚未招募未知

Pilot study to embed electronic Patient Reported Outcome Measures and patient reported experience measures into routine care for patients with Stage III MELanoma (ePROMs-MEL)

The University of Sydney0 个研究点目标入组 100 人开始时间: 2020年11月3日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patient key inclusion criteria:
  • Adults (over 18)
  • Diagnosis of Stage III melanoma at least 3 months earlier
  • Under the care of melanoma clinicians at MIA or RPAH
  • Sufficient English and cognitive ability to comprehend study materials, provide informed consent and participate in this study
  • Clinician inclusion criteria:
  • Clinicians currently treating and managing patients with stage III melanoma at Sydney Melanoma Surgical Oncology clinics at MIA or RPAH.

排除标准

  • 未提供

研究者

相似试验

Pilot study to embed electronic Patient Reported... | 临床试验